Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine

Rev Esp Cardiol (Engl Ed). 2022 Jul;75(7):614-616. doi: 10.1016/j.rec.2022.01.009. Epub 2022 Feb 21.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Myocarditis* / diagnosis
  • Myocarditis* / etiology

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine